Close Menu
Home » Telomere Length Linked to Genomic Alterations in 31 Cancers

Telomere Length Linked to Genomic Alterations in 31 Cancers

Jan 30, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Cancer cells use a variety of mechanisms to survive cellular crisis, including through telomere maintenance processes. By activating telomerase, cancer cells can counteract telomere shortening, and therefore avoid tumor-suppressing senescence and crisis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

  2. Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

    Premium

  3. At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

  4. Proteomic Subtypes Identified in Pan-Cancer Analysis

  5. Immunotherapy Regimens Yield Contrasting Results in Early Triple Negative Breast Cancer

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.